Yüklüyor......
Phase I trial of M(2)ES, a novel polyethylene glycosylated recombinant human endostatin, plus gemcitabine in advanced pancreatic cancer
Pancreatic cancer is one of the most lethal and resistant to treatment of solid tumors. Combination therapies with various types of drugs against pancreatic cancer have been extensively investigated. Endostatin is a potent endogenous inhibitor of angiogenesis, which may be administered in combinatio...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4051555/ https://ncbi.nlm.nih.gov/pubmed/24940500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.271 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|